doi: 10.3389/fphar.2021.627533 Goldstein, A
The peptide is metabolized by standard peptidase activity but shows unusual resistance to gastric acid degradation, with stability documented in pH as low as 1.5 for over 24 hours
This duration balances therapeutic benefits with manageable treatment commitment and cost considerations
It occupies a different mechanistic category from cognitive peptides like Semax or energy peptides like NAD+, which means there is no redundancy in combining them
Potential concerns include: Unknown product quality Contamination or sterility issues Incorrect dosing Injection site reactions Allergic or immune reactions Medication interactions Hormonal or metabolic effects Unclear long-term safety Lack of monitoring Delayed treatment for an actual injury or medical condition Medical oversight is especially important for patients with autoimmune conditions, cancer history, active infections, chronic inflammatory disorders, cardiovascular concerns, hormone-sensitive conditions, or complex medication regimens
